Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
16 angezeigte Treffer · Seite 3, keine Gesamtzahl für „cabozantinib“
Suchtreffer
Begriffe & Kennungen
Opdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of nephritis, immune mediat
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of pneumonitis including in
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of pneumonitis including in
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of rash was 62.8% (201/320)
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of rash was 62.8% (201/320)
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of thyroid disorders was 43
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the incidence of thyroid disorders was 43
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the proportion of patients who experience
Eintrag öffnenOpdivo · 4.8 · In patients treated with nivolumab in combination with cabozantinib, the proportion of patients who experience
Eintrag öffnenOpdivo · 4.8 · In the dataset of nivolumab 240 mg every 2 weeks in combination with cabozantinib 40 mg once daily in RCC (n =
Eintrag öffnenOpdivo · 4.8 · In the dataset of nivolumab intravenous formulation 240 mg every 2 weeks in combination with cabozantinib 40 m
Eintrag öffnenOpdivo · 4.8 · Nivolumab in combination with cabozantinib
Eintrag öffnenOpdivo · 4.8 · Nivolumab in combination with cabozantinib
Eintrag öffnencabozantinib
Eintrag öffnencabozantinib
Eintrag öffnencabozantinib (s)-malate
Eintrag öffnen